| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.02 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |